These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 7176335
1. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Millman S, Strauss AL, Parks JH, Coe FL. Kidney Int; 1982 Oct; 22(4):366-70. PubMed ID: 7176335 [Abstract] [Full Text] [Related]
2. Uric acid saturation in calcium nephrolithiasis. Coe FL, Strauss AL, Tembe V, Le Dun S. Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461 [Abstract] [Full Text] [Related]
4. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA. J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777 [Abstract] [Full Text] [Related]
5. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841 [Abstract] [Full Text] [Related]
6. Evaluation of factors involved in calcium stone formation. Abraham PA, Smith CL. Miner Electrolyte Metab; 1987 Apr; 13(3):201-8. PubMed ID: 3627051 [Abstract] [Full Text] [Related]
7. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers. Sriboonlue P, Prasongwattana V, Tungsanga K, Sitprija V. J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716 [Abstract] [Full Text] [Related]
8. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL. J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894 [Abstract] [Full Text] [Related]
9. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones. Prochaska M, Taylor E, Ferraro PM, Curhan G. J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983 [Abstract] [Full Text] [Related]
10. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Favus MJ, Coe FL. Scand J Urol Nephrol Suppl; 1980 May; 53():265-71. PubMed ID: 6938003 [Abstract] [Full Text] [Related]
11. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Pak CY, Peterson R. Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975 [Abstract] [Full Text] [Related]
13. Essential arterial hypertension and stone disease. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A. Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288 [Abstract] [Full Text] [Related]
14. Can 24-hour urine stone risk profiles predict urinary stone composition? Torricelli FC, De S, Liu X, Calle J, Gebreselassie S, Monga M. J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026 [Abstract] [Full Text] [Related]
15. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis. Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P, Borghi L, Gambaro G. J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247 [Abstract] [Full Text] [Related]
16. Urinary Risk Profile, Impact of Diet, and Risk of Calcium Oxalate Urolithiasis in Idiopathic Uric Acid Stone Disease. Siener R, Löhr P, Hesse A. Nutrients; 2023 Jan 21; 15(3):. PubMed ID: 36771279 [Abstract] [Full Text] [Related]
17. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Parks JH, Coward M, Coe FL. Kidney Int; 1997 Mar 21; 51(3):894-900. PubMed ID: 9067927 [Abstract] [Full Text] [Related]
18. The effect of glucose intake on urine saturation with calcium oxalate, calcium phosphate, uric acid and sodium urate. Głuszek J. Int Urol Nephrol; 1988 Mar 21; 20(6):657-64. PubMed ID: 3229936 [Abstract] [Full Text] [Related]
19. Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M. Nephrol Dial Transplant; 2006 Jul 21; 21(7):1870-5. PubMed ID: 16595587 [Abstract] [Full Text] [Related]
20. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients. Rapado A, Castrillo JM, Diaz-Curiel M, Traba ML, Santos M, Cifuentes-Delatte L. Adv Exp Med Biol; 1980 Jul 21; 122A():109-13. PubMed ID: 7424622 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]